Dimensional Fund Advisors LP raised its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 3.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,035,069 shares of the company's stock after buying an additional 36,846 shares during the quarter. Dimensional Fund Advisors LP owned 3.75% of ZimVie worth $18,889,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Gabelli Funds LLC increased its holdings in ZimVie by 2.0% in the 1st quarter. Gabelli Funds LLC now owns 41,060 shares of the company's stock valued at $677,000 after buying an additional 800 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in ZimVie by 6.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company's stock valued at $356,000 after buying an additional 1,275 shares during the period. Scarborough Advisors LLC bought a new stake in ZimVie in the 4th quarter valued at $28,000. Russell Investments Group Ltd. increased its holdings in ZimVie by 0.7% in the 1st quarter. Russell Investments Group Ltd. now owns 281,377 shares of the company's stock valued at $4,640,000 after buying an additional 1,964 shares during the period. Finally, Summit Securities Group LLC increased its holdings in ZimVie by 518.6% in the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company's stock valued at $55,000 after buying an additional 2,515 shares during the period. Institutional investors own 95.63% of the company's stock.
Wall Street Analyst Weigh In
Separately, Needham & Company LLC boosted their target price on shares of ZimVie from $20.00 to $23.00 and gave the company a "buy" rating in a research note on Friday, August 2nd.
View Our Latest Report on ZIMV
Insider Buying and Selling
In related news, major shareholder Camber Capital Management Lp sold 525,000 shares of the company's stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the transaction, the insider now owns 2,725,000 shares in the company, valued at $48,259,750. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 3.01% of the stock is owned by corporate insiders.
ZimVie Price Performance
Shares of NASDAQ:ZIMV traded up $0.31 on Friday, hitting $15.96. The stock had a trading volume of 148,738 shares, compared to its average volume of 336,365. ZimVie Inc. has a twelve month low of $6.52 and a twelve month high of $22.40. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.43 and a current ratio of 1.94. The firm's 50 day moving average price is $17.11 and its 200-day moving average price is $17.08. The company has a market capitalization of $440.02 million, a price-to-earnings ratio of -1.14 and a beta of 2.12.
ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its earnings results on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.04). The firm had revenue of $116.81 million during the quarter. ZimVie had a negative net margin of 63.84% and a positive return on equity of 2.21%. During the same quarter in the previous year, the company earned $0.17 EPS. On average, equities research analysts predict that ZimVie Inc. will post 0.63 earnings per share for the current year.
About ZimVie
(
Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Recommended Stories
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.